Viral attachment and entry machinery

Viral attachment and entry machinery refers to the collective set of viral surface proteins and host cell receptors that facilitate the initial stages of viral infection. This process typically involves the binding of viral glycoproteins, such as the HIV-1 gp120 or the SARS-CoV-2 spike protein, to specific host receptors like CD4 or ACE2 (Marsh and Helenius, 2006). Following attachment, the machinery undergoes conformational changes to trigger membrane fusion or endocytosis, allowing the viral genetic material to enter the host cell (Maginnis, 2018). Because this step is essential for the viral life cycle, these proteins are primary targets for antiviral drug development, including fusion inhibitors and receptor antagonists (NIH, 2023). Drugs targeting this machinery, such as Maraviroc or Enfuvirtide, aim to prevent the virus from ever entering the host cell, thereby stopping the infection at its earliest stage. However, the high mutation rate of viral surface proteins often leads to the rapid emergence of resistance, posing a significant challenge for therapeutic efficacy (V'kovski et al., 2021).

Other names

Viral entry proteinsViral fusion machineryViral attachment proteinsEntry receptorsViral envelope glycoproteins

Inhibition of viral attachment to host receptors, blockade of host co-receptors, and prevention of viral-host membrane fusion or endocytic uptake (StatPearls, 2023).